Amanta Healthcare Limited share price
NSE: AMANTA · ISIN INE084K01015
Key numbers
- Market cap
- ₹ 722 Cr
- Current price
- ₹ 186.00
- 52-week high / low
- ₹ 210 / 92
- Stock P/E
- 49.2
- Book value
- ₹ 64.1
- Dividend yield
- 0.00%
- ROCE
- 10.9%
- ROE
- 9.4%
- Debt to equity
- 1.11
- Sales growth (3 yrs)
- 3.3%
- Profit growth (3 yrs)
- -
- 1-year return
- 29.4%
About Amanta Healthcare Limited
Amanta Healthcare Limited operates as a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products and parenteral products in Africa, Latin America, the United Kingdom, and internationally. The company manufactures its products in three product group segments Large Volume Parenteral, Nipple Head (Single Port), SteriPort (Two Ports), and Small Volume Parenteral. Additionally, it manufactures medical devices and fluid therapy - (IV Fluid), formulations, diluents, ophthalmic, respiratory care and irrigation solutions in therapeutic segment and products, such as irrigation, first-aid solution, and eye lubricants in medical device segment. It also offers a wide range of closure systems, such as nipple head, twist-off, and screw types and container fill-volume ranging from 2ml to 1000 ml. Its markets its products through three strategic business units including national sales, international sales, and product partnering with various foreign and Indian pharmaceutical companies. Amanta Healthcare Limited was formerly known as Marck Biosciences Limited and changed its name to Amanta Healthcare Limited in June 2014. Amanta Healthcare…
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 65 | 71 | 74 | 77 | 69 |
| Operating profit | 15 | 15 | 15 | 15 | 15 |
| Net profit | 4 | 1 | 5 | 6 | 3 |
| EPS (₹) | 0.90 | 0.35 | 1.35 | 1.61 | 0.85 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.